Operating through 123 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared,non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 370,000 TMS treatments to close to 10,000 patients struggling with depression.
(CA) Burcon is a global technology leader in the development of clean-label, plant-based proteins for foods and beverages. With over 290 issued patents and 200 additional patent applications developed over a span of more than 20 years, Burcon has grown an extensive portfolio of composition, application and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation ("Merit Foods") was established between Burcon and three veteran food industry executives. Merit Foods has built a state-of-the-art protein production facility in Manitoba, Canada to produce, under licence, Burcon’s novel pea and canola protein ingredients.
(US) Viracta is a precision oncology company targeting virus-associated malignancies. The Company's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphomas. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.
(US) transphorm is a global semiconductor company that develops gallium nitride (gan) transistors and modules for high-voltage power conversion applications. built on an industry-leading ip portfolio and over 300 years of combined gan engineering expertise, transphorm is delivering the highest performance and highest reliability gan devices and best-in-class applications-driven design support to a growing customer base. transphorm is creating innovations that move beyond the limitations of silicon to capture 90% of today’s energy losses. with the industry's only fully-qualified 650v gan devices in production, including testing beyond jedec and extensive qualification and long-term reliability of all devices, transphorm's reliability is unmatched by any gan manufacturer.
Based in Albany, New York, MTI Instruments, Inc., a wholly-owned subsidiary of Mechanical Technology, Incorporated, is a global leader in non-contact measurement tools and condition-based monitoring systems with a growing customer base spanning more than 60 countries. MTI Instruments has a rich history in innovation for developing and manufacturing sensors and systems to help clients secure the highest level of accurate measurements in order to drive innovation, identify efficiencies and increase competitiveness. MTI Instruments provides comprehensive solutions to better address challenges and applications within numerous industries, including industrial manufacturing, consumer electronics, semiconductor, solar, commercial and military aviation, automotive, transportation and R&D.
headquartered in seattle, washington, jones soda co.® (otcqb: jsda) markets and distributes premium beverages under the jones® soda, jones zilch® and jones stripped™ brands. a leader in the premium soda category, jones soda is known for its variety of flavors, high quality ingredients (including cane sugar), and innovative labeling technique that incorporates always-changing photos sent in from its consumers. the diverse product line of jones offers something for everyone – cane sugar soda, zero-calorie soda and an all-naturally sweetened sparkling beverage with only 30 calories and 8 grams of sugar. jones soda is sold primarily through traditional beverage retailers and in many retailers you would not expect to find carbonated beverages across north america. for more information, please visit us at www.jonessoda.com or www.myjones.com.
globally, 4.5 billion people lack access to safely managed sanitation, with enormous costs to society. energy efficient sanitation with water reuse is needed to address future water scarcity. 374water offer prefabricated, compact and superior treatment systems utilizing supercritical water oxidation technology that converts organic waste to clean water in seconds, eliminating all pathogens and micropollutants, while recovering energy and nutrients.
scoutcam inc. develops and manufactures customized visual solutions for organizations across various industries in the form of highly resistant micro cameras and supplementary technologies. its smallest cameras with high resolution technology has unique properties that have been authenticated by customers, such as nasa in the environmental conditions, including extreme temperatures, vibrations, and radiation. its devices are used in the medical, aerospace, industrial, research, and defense industries. scoutcam inc. was founded in 2019 and is based in omer, israel.
(BM) Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch "Vants" - nimble and focused biopharmaceutical and health technology companies
(US) Alto Ingredients, Inc., formerly known as Pacific Ethanol, Inc., is a leading producer of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company's customers include major food and beverage companies and consumer products companies.
(United States) Ipsidy, Inc. rebranded as authID.ai Recognise Your Customer™. Its mission is to eliminate all passwords, and to be the preferred global platform for biometric identity authentication. The authID.ai Identity as a Service (IDaaS) platform delivers a suite of biometric Its proofing and authentication solutions that establish security and trust in today’s digital world. Its vision is to enable every organization to “Recognise Your Customer” instantly, without friction or loss of privacy, powered by the most sophisticated biometric and artificial intelligence technologies.
PQ Group Holdings Inc. and subsidiaries is a leading integrated and innovative global provider of specialty catalysts, materials, chemicals and services. We support customers globally through our strategically located network of manufacturing facilities. PQ Group has four uniquely positioned specialty businesses: Refining Services provides sulfuric acid recycling to the North American refining industry; Catalysts serves the packaging and engineering plastics and the global refining, petrochemical and emissions control industries; Performance Materials produces transportation reflective safety markings for roads and airports; and Performance Chemicals supplies diverse product end uses, including personal and industrial cleaning products, fuel-efficient tires, surface coatings, and food and beverage products. PQ Group serves over 4,000 customers globally across many end uses and operate over 70 manufacturing facilities which are strategically located across six continents.
(CH) Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. The Company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125, in Phase 2) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201, post Phase 1b). Through its affiliate Altamira Medica, the Company is developing a nasal spray for protection against airborne pathogens and allergens (AM-301). In addition, Auris Medical has two Phase 3 programs under development: Sonsuvi® (AM-111) for acute inner ear hearing loss and Keyzilen® (AM-101) for acute inner ear tinnitus. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Auris Medical Holding Ltd. trade on the NASDAQ Capital Market under the symbol 'EARS.'
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore’s most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies.
Intercure Ltd operates as a cannabis company. The Company produces and distributes cannabis products for medical treatments. Intercure serves clients worldwide.